VLA 0.00% $1.75 viralytics limited

Phase 2, Phase 3, Phase 4, page-27

  1. 1,599 Posts.
    lightbulb Created with Sketch. 106
    Merck are presenting. All Merck have to do is refer to the early Keytruda/Cavatak combination trial data in front of this audience and we will hit Bell potter's target in no time.
 
watchlist Created with Sketch. Add VLA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.